Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

21.44
Delayed Data
As of Apr 29
 -0.17 / -0.79%
Today’s Change
10.60
Today|||52-Week Range
42.25
-19.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization152.0K171.0K175.0K236.0K
 
 
 
 
 
 
Operating ExpensesGross Income-152.0K-171.0K-175.0K-236.0K
 
 
 
 
 
General Expenses20.2M22.8M22.3M30.8M
 
 
 
 
 
Research And Development14.5M16.2M14.2M16.3M
 
 
 
 
 
Total Operating Expenses20.4M23.0M22.5M31.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.4M-23.0M-22.5M-31.1M
 
 
 
 
 
Interest Expense On Debt210.0K237.0K242.0K247.0K
 
 
 
 
 
Other Expenses0.00144.0K61.0K65.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.6M-23.1M-22.7M-31.2M
 
 
 
 
 
Net Income-20.6M-23.1M-22.7M-31.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS29.4M31.0M35.8M36.0M
 
 
 
 
 
Shares To Calculate EPS Diluted29.4M31.0M35.8M36.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.70-$0.74-$0.63-$0.87
 
 
 
 
 
EPS Diluted-$0.70-$0.74-$0.63-$0.87